Supreme Court Questions Sackler Shield in Purdue Opioid Pact (2)

The US Supreme Court signaled a likely divide over Purdue Pharma LP’s $6 billion opioid settlement, as the justices weighed Biden administration contentions that the accord improperly shields the Sackler family members who own the company.

In a Monday argument that cut across the court’s normal ideological divides, some justices questioned whether the Sacklers should get the benefit of a legal shield when they haven’t filed for bankruptcy themselves.

“Why should they get the discharge that usually goes to a bankrupt person once they’ve put all their assets on the table, without having put all their assets on the ...